Editorial: What can we learn from gene expression profiling for adrenal tumor management?

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 3, 2005, Pages 1900-1902

  Bornstein, Stefan R ^a,c   Hornsby, Peter J ^b  

^a Department of Medicine ^*  (Germany)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYCLIN E; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OSTEOPONTIN; SOMATOMEDIN B; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR GATA 4;

ADRENAL CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SURGERY; CARCINOGENESIS; COMPUTER ASSISTED TOMOGRAPHY; DNA MICROARRAY; EDITORIAL; GENE EXPRESSION PROFILING; HUMAN; LEARNING; MARKER GENE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RECURRENT CANCER; STEROIDOGENESIS; TUMOR VOLUME; ULTRASOUND; ADRENAL TUMOR; GENE EXPRESSION REGULATION; GENETICS; NOTE;

ADRENAL GLAND NEOPLASMS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS;

EID: 16244377772     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2005-0065     Document Type: Editorial

References (21)

1. Bornstein SR, Stratakis CA, Chrousos GP 1999 Adrenocortical tumors: recent advances in basic concepts and clinical management. Ann Intern Med 130:759-771
2. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y, Bornstein SR 2004 The clinically inapparent adrenal mass: update in diagnosis and management. Endocr Rev 25:309-340
3. Beuschlein F, Reincke M, Karl M, Travis WD, Jaursch-Hancke C, Abdelhamid S, Chrousos GP, Allolio B 1994 Clonal composition of human adrenocortical neoplasms. Cancer Res 54:4927-4932
4. de Fraipont F, El Atifi M, Cherradi N, Le Moigne G, Defaye G, Houlgatte R, Bertherat J, Bertagna X, Plouin P-F, Baudin E, Berger F, Gicquel C, Chabre O, Feige J-J 2005 Gene expression profiling of human adrenocortical tumors using complementary deoxyribonucleic acid microarrays identifies several candidate genes as markers of malignancy. J Clin Endocrinol Metab 90:1819-1829
5. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson Jr J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JO, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO, Staudt LM 2000 Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511
6. Macgregor PF 2003 Gene expression in cancer: the application of microarrays. Expert Rev Mol Diagn 3:185-200
7. Russo G, Zegar C, Giordano A 2003 Advantages and limitations of microarray technology in human cancer. Oncogene 22:6497-6507
8. Giordano TJ, Thomas DG, Kuick R, Lizyness M, Misek DE, Smith AL, Sanders D, Aljundi RT, Gauger PG, Thompson NW, Taylor JM, Hanash SM 2003 Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis. Am J Pathol 162:521-531
9. Fottner C, Hoeflich A, Wolf E, Weber MM 2004 Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis. Horm Metab Res 36:397-405
10. Schorge JO, Drake RD, Lee H, Skates SJ, Rajanbabu R, Miller DS, Kim JH, Cramer DW, Berkowitz RS, Mok SC 2004 Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer. Clin Cancer Res 10:3474-3478
11. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, Bornstein SR 2002 Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71
12. Bornstein SR, Zacharowski P, Schumann RR, Barthel A, Tran N, Papewalis C, Rettori V, McCann SM, Schulze-Osthoff K, Scherbaum WA, Tarnow J, Zacharowski K 2004 Impaired adrenal stress response in Toll-like receptor 2-deficient mice. Proc Natl Acad Sci USA 101:16695-16700
13. Schteingart DE, Giordano TJ, Benitez RS, Burdick MD, Starkman MN, Arenberg DA, Stricter RM 2001 Overexpression of CXC chemokines by an adrenocortical carcinoma: a novel clinical syndrome. J Clin Endocrinol Metab 86:3968-3974
14. Mocellin S, Wang E, Panelli M, Pilati P, Marincola FM 2004 DNA array-based gene profiling in tumor immunology. Clin Cancer Res 10:4597-4606
15. Wolkersdörfer GW, Marx C, Brown J, Schröder S, Füssel M, Rieber EP, Kuhlisch E, Ehninger G, Bornstein SR 2005 Prevalence of HLA-DRB1 genotype and altered Fas/Fas ligand expression in adrenocortical carcinoma. J Clin Endocrinol Metab 90:1768-1774
16. Barbosa AS, Giacaglia LR, Martin RM, Mendonca BB, Lin CJ 2004 Assessment of the role of transcript for GATA-4 as a marker of unfavorable outcome in human adrenocortical neoplasms. BMC Endocr Disord 4:3
17. Lefrancois-Martinez AM, Bertherat J, Val P, Tournaire C, Gallo-Payet N, Hyndman D, Veyssiere G, Bertagna X, Jean C, Martinez A 2004 Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. J Clin Endocrinol Metab 89:3010-3019
18. Tissier F, Louvel A, Grabar S, Hagnere AM, Bertherat J, Vacher-Lavenu MC, Dousset B, Chapuis Y, Bertagna X, Gicquel C 2004 Cyclin E correlates with malignancy and adverse prognosis in adrenocortical tumors. Eur J Endocrinol 150:809-817
19. Willenberg HS, Walters R, Bornstein SR 2002 Use of laser microdissection in complex tissue. Methods Enzymol 356:216-223
20. Stratakis CA 2003 Genetics of adrenocorrical tumors: gatekeepers, landscapers and conductors in symphony. Trends Endocrinol Metab 14:404-410
21. Sun B, Huang Q, Liu S, Chen M, Hawks CL, Wang L, Zhang C, Hornsby PJ 2004 Progressive loss of malignant behavior in telomerase-negative tumorigenic adrenocorrical cells and restoration of tumorigenicity by human telomerase reverse transcriptase. Cancel Res 64:6144-6151